Green B, Grant R, Richie C, Chatterjee B, Sampaio De Melo M, Barr F, et al. Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis. Eur J Endocrinol. 2022;187:185-196 pubmed publisher

Biavasco R, Lettera E, Giannetti K, Gilioli D, Beretta S, Conti A, et al. Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis. Nat Commun. 2021;12:4559 pubmed publisher

Nagasawa I, Koido M, Tani Y, Tsukahara S, Kunimasa K, Tomida A. Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy. iScience. 2020;23:101028 pubmed publisher

Mohsen M, Ji D, Kool E. Polymerase synthesis of four-base DNA from two stable dimeric nucleotides. Nucleic Acids Res. 2019;47:9495-9501 pubmed publisher

Röck R, Mayrhofer J, Torres Quesada O, Enzler F, Raffeiner A, Raffeiner P, et al. BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS. Sci Adv. 2019;5:eaav8463 pubmed publisher

Rad Pour S, Morikawa H, Kiani N, Yang M, Azimi A, Shafi G, et al. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma. Sci Rep. 2019;9:12150 pubmed publisher

Wang X, Xu X, Peng C, Qin Y, Gao T, Jing J, et al. BRAFV600E-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT. Oncol Lett. 2019;18:927-935 pubmed publisher

Chen M, Myers A, Markey M, Long W. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness. J Cell Physiol. 2019;234:13220-13232 pubmed publisher

Sengupta S, Sun S, Huang K, Oh C, Bailey M, Varghese R, et al. Integrative omics analyses broaden treatment targets in human cancer. Genome Med. 2018;10:60 pubmed publisher

Cope N, Candelora C, Wong K, Kumar S, Nan H, Grasso M, et al. Mechanism of BRAF Activation through Biochemical Characterization of the Recombinant Full-Length Protein. Chembiochem. 2018;19:1988-1997 pubmed publisher

Martínez Limón A, Alriquet M, Lang W, Calloni G, Wittig I, Vabulas R. Recognition of enzymes lacking bound cofactor by protein quality control. Proc Natl Acad Sci U S A. 2016;113:12156-12161 pubmed

Chakraborty R, Hampton O, Shen X, Simko S, Shih A, Abhyankar H, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014;124:3007-15 pubmed publisher